Back to resultsStrategies to Reduce Addiction Stigma Among Health Professionals
Primary Purpose
Opioid Use Disorder, Substance Use Disorders, Stigma, Social
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Words Matter - Visual Campaign
Words Matter - Visual Campaign & Narrative Vignette (Messenger: Person with Opioid Use Disorder) Experimental: Words Matter - Visual Campaign & Narrative Vignette (Messenger: Clinician)
Words Matter - Visual Campaign & Narrative Vignette (Messenger: Clinician)
Words Matter - Visual Campaign & Narrative Vignette (Messenger: Health System Administrator)
Medication Treatment for Opioid Use Disorder Works - Visual Campaign
Medication Treatment for Opioid Use Disorder Works - Visual Campaign & Narrative Vignette (Messenger: Person with Opioid Use Disorder)
Medication Treatment for Opioid Use Disorder Works - Visual Campaign & Narrative Vignette (Messenger: Clinician)
Medication Treatment for Opioid Use Disorder Works - Visual Campaign & Narrative Vignette (Messenger: Health System Administrator)
Sponsored by
About this trial
This is an interventional other trial for Opioid Use Disorder
Eligibility Criteria
Inclusion Criteria:
- employed as health professional in the United States, including clinicians (e.g., physicians, nurses, physician assistants, pharmacists, and optometrists), technicians and technologists (e.g., laboratory technologist or technician, emergency medical technician, paramedic, licensed practical or licensed vocational nurse, medical records or health information technician, etc.), health aids and assistants (e.g., nursing aide, home health aide, medical assistant, pharmacy aide, phlebotomist, etc.)
- participant in existing web-based survey panel (IPSOS's KnowledgeNetworks panel and partner opt-in panel)
Exclusion Criteria:
- not employed in health profession
- not able to complete experiment and survey in English
Sites / Locations
- Johns Hopkins Bloomberg School of Public Health
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm 5
Arm 6
Arm 7
Arm 8
Arm 9
Arm Type
No Intervention
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Arm Label
No exposure control group
Words Matter - Visual Campaign
Words Matter - Visual Campaign & Narrative Vignette (Messenger: Person with Opioid Use Disorder)
Words Matter - Visual Campaign & Narrative Vignette (Messenger: Clinician)
Words Matter - Visual Campaign & Narrative Vignette (Messenger: Health System Administrator)
Medication Treatment Works - Visual Campaign
Medication Treatment Works - Visual Campaign & Narrative Vignette (Person with OUD)
Medication Treatment Works - Visual Campaign & Narrative Vignette (Clinician)
Medication Treatment Works - Visual Campaign & Narrative Vignette (Health System Administrator)
Arm Description
This group was not exposed to any message frame.
Participants randomized to this arm were exposed to a visual campaign communicating the importance of use of non-stigmatizing language regarding substance use disorder and opioid use disorder in clinical settings.
Participants randomized to this arm were exposed to a visual campaign communicating the importance of use of non-stigmatizing language regarding substance use disorder and opioid use disorder in clinical settings and a narrative vignette told from the perspective of a person with opioid use disorder.
Participants randomized to this arm were exposed to a visual campaign communicating the importance of use of non-stigmatizing language regarding substance use disorder and opioid use disorder in clinical settings and a narrative vignette told from the perspective of a clinician.
Participants randomized to this arm were exposed to a visual campaign communicating the importance of use of non-stigmatizing language regarding substance use disorder and opioid use disorder in clinical settings and a narrative vignette told from the perspective of a health system administrator/leader.
Participants randomized to this arm were exposed to a visual campaign communicating the effectiveness of medications for treating opioid use disorder in saving lives.
Participants randomized to this arm were exposed to a visual campaign communicating the effectiveness of medications for treating opioid use disorder in saving lives and a narrative vignette told from the perspective of a person with opioid use disorder.
Participants randomized to this arm were exposed to a visual campaign communicating the effectiveness of medications for treating opioid use disorder in saving lives and a narrative vignette told from the perspective of a clinician.
Participants randomized to this arm were exposed to a visual campaign communicating the effectiveness of medications for treating opioid use disorder in saving lives and a narrative vignette told from the perspective of a health system administrator/leader.
Outcomes
Primary Outcome Measures
Rating of willingness to have person with opioid use disorder marry into their family
Item from the Social Distance Scale that measures one element of stigma (desire for social distance). Measured on 5-point Likert scale with 5 indicating greater unwillingness and 1 indicating greater willingness to have a person with opioid use disorder marry into the family. Measured via survey questionnaire.
Rating of willingness to have person with opioid use disorder as a neighbor
Item from the Social Distance Scale that measures one element of stigma (desire for social distance). Measured on 5-point Likert scale with 5 indicating greater unwillingness and 1 indicating greater willingness to have a person with opioid use disorder as a neighbor. Measured via survey questionnaire.
Rating of agreement that opioid use disorder is a medical condition
Rating of agreement with statement "Opioid use disorder is a chronic medical condition like diabetes mellitus" on 5-point Likert scale with 5 indicating strong disagreement and 1 indicating strong agreement. Measured via survey questionnaire.
Rating of agreement that individuals with opioid use disorder are to blame
Rating of agreement with statement "Individuals with opioid use disorder only have themselves to blame for their problem" on 5-point Likert scale with 5 indicating strong disagreement and 1 indicating strong agreement. Measured via survey questionnaire.
Rating of support for increasing government spending on opioid use disorder treatment
Rating of support for increasing government spending on treatment of opioid use disorder with 5 indicating strongly favoring and 1 indicating strongly opposing. Measured via survey questionnaire.
Feeling thermometer measure of warmth toward people with opioid use disorder
Rating of warmth felt toward people with opioid use disorder with 0 indicating extremely cold and 100 indicating extremely warm. Measured via survey questionnaire.
Secondary Outcome Measures
Stigmatizing Language - Addict
Rating of agreement that term "addict" appropriate in a clinical care setting with 1 indicating strongly agree (that term is appropriate) and 5 indicating strongly disagree (that term is appropriate). Measured via survey questionnaire.
Stigmatizing Language - Substance abuse
Rating of agreement that term "substance abuse" appropriate in a clinical care setting with 1 indicating strongly agree (that term is appropriate) and 5 indicating strongly disagree (that term is appropriate). Measured via survey questionnaire.
Stigmatizing Language - dirty
Rating of agreement that term "'dirty' in reference to the result from a drug test" appropriate in a clinical care setting with 1 indicating strongly agree (that term is appropriate) and 5 indicating strongly disagree (that term is appropriate). Measured via survey questionnaire.
Stigmatizing Language - clean
Rating of agreement that term "'clean' in reference to the result from a drug test" appropriate in a clinical care setting with 1 indicating strongly agree (that term is appropriate) and 5 indicating strongly disagree (that term is appropriate). Measured via survey questionnaire.
Stigmatizing Language - addicted baby
Rating of agreement that term "addicted baby" appropriate in a clinical care setting with 1 indicating strongly agree (that term is appropriate) and 5 indicating strongly disagree (that term is appropriate). Measured via survey questionnaire.
Stigmatizing Language - person with substance use disorder
Rating of agreement that term "person with substance use disorder" appropriate in a clinical care setting with 1 indicating strongly agree (that term is appropriate) and 5 indicating strongly disagree (that term is appropriate). Measured via survey questionnaire.
Stigmatizing Language - substance use
Rating of agreement that term "substance use" appropriate in a clinical care setting with 1 indicating strongly agree (that term is appropriate) and 5 indicating strongly disagree (that term is appropriate). Measured via survey questionnaire.
Stigmatizing Language - negative test result
Rating of agreement that term "negative test result" appropriate in a clinical care setting with 1 indicating strongly agree (that term is appropriate) and 5 indicating strongly disagree (that term is appropriate). Measured via survey questionnaire.
Stigmatizing Language - positive test result
Rating of agreement that term "positive test result" appropriate in a clinical care setting with 1 indicating strongly agree (that term is appropriate) and 5 indicating strongly disagree (that term is appropriate). Measured via survey questionnaire.
Stigmatizing Language - baby born with neonatal opioid withdrawal syndrome
Rating of agreement that term "baby born with neonatal opioid withdrawal syndrome" appropriate in a clinical care setting with 1 indicating strongly agree (that term is appropriate) and 5 indicating strongly disagree (that term is appropriate). Measured via survey questionnaire.
Willingness to sign pledge committing to using non-stigmatizing language
Binary (yes/no) measure of whether participant is willing to sign a pledge committing to using non-stigmatizing language related to substance use disorder in clinical settings. Measured via survey questionnaire.
Perception of opioid use disorder treatment effectiveness
Participant perception of whether there is a treatment for opioid use disorder that is effective for a long period of time (three close-ended response options: yes, there is a treatment; no, there isn't such a treatment; don't know). Measured via survey questionnaire.
Rating of willingness to have person taking medication marry into their family
Rating of willingness to have person taking medication to treat opioid use disorder marry into family. Item from the Social Distance Scale that measures one element of stigma (desire for social distance). Measured on 5-point Likert scale with 5 indicating greater unwillingness and 1 indicating greater willingness to have a person taking medication to treat opioid use disorder marry into the family. Measured via survey questionnaire.
Rating of willingness to have person taking medication marry as a neighbor
Rating of willingness to have person taking medication to treat opioid use disorder as a neighbor. Item from the Social Distance Scale that measures one element of stigma (desire for social distance). Measured on 5-point Likert scale with 5 indicating greater unwillingness and 1 indicating greater willingness to have a person taking medication to treat opioid use disorder as a neighbor. Measured via survey questionnaire.
Rating of strength/weakness of person taking medication
Rating of strength/weakness of person taking medication to treat opioid use disorder on 5-point Likert scale with 5 indicating strong and 1 indicating weak. This is a semantic differential measure. Measured via survey questionnaire.
Rating of agreement that recovery is possible
Rating of agreement with statement "Most people with opioid use disorder will, with medication treatment, get well and return to productive lives" on a 5-point Likert scale with 5 indicating strongly disagree and 1 indicating strongly agree. Measured via survey questionnaire.
Feeling thermometer measure of warmth toward people taking medication
Rating of warmth felt toward people taking medication to treat opioid use disorder with 0 indicating extremely cold and 100 indicating extremely warm. Measured via survey questionnaire.
Full Information
NCT ID
NCT05127707
First Posted
October 28, 2021
Last Updated
November 8, 2021
Sponsor
Johns Hopkins Bloomberg School of Public Health
1. Study Identification
Unique Protocol Identification Number
NCT05127707
Brief Title
Strategies to Reduce Addiction Stigma Among Health Professionals
Official Title
Effect of Exposure to Visual Campaigns and Narrative Vignettes on Addiction Stigma Among Health Professionals: A Randomized Experiment
Study Type
Interventional
2. Study Status
Record Verification Date
November 2021
Overall Recruitment Status
Completed
Study Start Date
November 13, 2020 (Actual)
Primary Completion Date
November 30, 2020 (Actual)
Study Completion Date
November 30, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Johns Hopkins Bloomberg School of Public Health
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim of this study was to evaluate the effects of exposure to stigma reduction message frames communicated by visual campaigns and narrative vignettes among a national sample of health professionals.
Detailed Description
This randomized experiment evaluated the impact of exposure to message frames communicating the importance of non-stigmatizing language regarding addiction and the effectiveness of medication treatment for opioid use disorder delivered through a visual campaign alone or through a visual campaign in addition to a narrative vignette from the perspective of one of three messengers (a person with opioid use disorder, a clinician, or a health system leader) on attitudes toward people with opioid use disorder and medications for treating opioid use disorder among a national sample of health professionals.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Opioid Use Disorder, Substance Use Disorders, Stigma, Social
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
1842 (Actual)
8. Arms, Groups, and Interventions
Arm Title
No exposure control group
Arm Type
No Intervention
Arm Description
This group was not exposed to any message frame.
Arm Title
Words Matter - Visual Campaign
Arm Type
Experimental
Arm Description
Participants randomized to this arm were exposed to a visual campaign communicating the importance of use of non-stigmatizing language regarding substance use disorder and opioid use disorder in clinical settings.
Arm Title
Words Matter - Visual Campaign & Narrative Vignette (Messenger: Person with Opioid Use Disorder)
Arm Type
Experimental
Arm Description
Participants randomized to this arm were exposed to a visual campaign communicating the importance of use of non-stigmatizing language regarding substance use disorder and opioid use disorder in clinical settings and a narrative vignette told from the perspective of a person with opioid use disorder.
Arm Title
Words Matter - Visual Campaign & Narrative Vignette (Messenger: Clinician)
Arm Type
Experimental
Arm Description
Participants randomized to this arm were exposed to a visual campaign communicating the importance of use of non-stigmatizing language regarding substance use disorder and opioid use disorder in clinical settings and a narrative vignette told from the perspective of a clinician.
Arm Title
Words Matter - Visual Campaign & Narrative Vignette (Messenger: Health System Administrator)
Arm Type
Experimental
Arm Description
Participants randomized to this arm were exposed to a visual campaign communicating the importance of use of non-stigmatizing language regarding substance use disorder and opioid use disorder in clinical settings and a narrative vignette told from the perspective of a health system administrator/leader.
Arm Title
Medication Treatment Works - Visual Campaign
Arm Type
Experimental
Arm Description
Participants randomized to this arm were exposed to a visual campaign communicating the effectiveness of medications for treating opioid use disorder in saving lives.
Arm Title
Medication Treatment Works - Visual Campaign & Narrative Vignette (Person with OUD)
Arm Type
Experimental
Arm Description
Participants randomized to this arm were exposed to a visual campaign communicating the effectiveness of medications for treating opioid use disorder in saving lives and a narrative vignette told from the perspective of a person with opioid use disorder.
Arm Title
Medication Treatment Works - Visual Campaign & Narrative Vignette (Clinician)
Arm Type
Experimental
Arm Description
Participants randomized to this arm were exposed to a visual campaign communicating the effectiveness of medications for treating opioid use disorder in saving lives and a narrative vignette told from the perspective of a clinician.
Arm Title
Medication Treatment Works - Visual Campaign & Narrative Vignette (Health System Administrator)
Arm Type
Experimental
Arm Description
Participants randomized to this arm were exposed to a visual campaign communicating the effectiveness of medications for treating opioid use disorder in saving lives and a narrative vignette told from the perspective of a health system administrator/leader.
Intervention Type
Behavioral
Intervention Name(s)
Words Matter - Visual Campaign
Intervention Description
Visual campaign emphasizing the importance of using non-stigmatizing language related to substance use and opioid use disorder in clinical settings.
Intervention Type
Behavioral
Intervention Name(s)
Words Matter - Visual Campaign & Narrative Vignette (Messenger: Person with Opioid Use Disorder) Experimental: Words Matter - Visual Campaign & Narrative Vignette (Messenger: Clinician)
Intervention Description
Visual campaign emphasizing the importance of using non-stigmatizing language related to substance use and opioid use disorder in clinical settings combined with a narrative vignette told from the perspective of a person with opioid use disorder
Intervention Type
Behavioral
Intervention Name(s)
Words Matter - Visual Campaign & Narrative Vignette (Messenger: Clinician)
Intervention Description
Visual campaign emphasizing the importance of using non-stigmatizing language related to substance use and opioid use disorder in clinical settings combined with a narrative vignette told from the perspective of a clinician working with patients with opioid use disorder
Intervention Type
Behavioral
Intervention Name(s)
Words Matter - Visual Campaign & Narrative Vignette (Messenger: Health System Administrator)
Intervention Description
Visual campaign emphasizing the importance of using non-stigmatizing language related to substance use and opioid use disorder in clinical settings combined with a narrative vignette told from the perspective of a health system administrator/leader
Intervention Type
Behavioral
Intervention Name(s)
Medication Treatment for Opioid Use Disorder Works - Visual Campaign
Intervention Description
Visual campaign emphasizing the effectiveness and value of medications to treat opioid use disorder in saving lives
Intervention Type
Behavioral
Intervention Name(s)
Medication Treatment for Opioid Use Disorder Works - Visual Campaign & Narrative Vignette (Messenger: Person with Opioid Use Disorder)
Intervention Description
Visual campaign emphasizing the effectiveness and value of medications to treat opioid use disorder in saving lives combined with a narrative vignette told from the perspective of a person with opioid use disorder
Intervention Type
Behavioral
Intervention Name(s)
Medication Treatment for Opioid Use Disorder Works - Visual Campaign & Narrative Vignette (Messenger: Clinician)
Intervention Description
Visual campaign emphasizing the effectiveness and value of medications to treat opioid use disorder in saving lives combined with a narrative vignette told from the perspective of a clinician who treats people with opioid use disorder
Intervention Type
Behavioral
Intervention Name(s)
Medication Treatment for Opioid Use Disorder Works - Visual Campaign & Narrative Vignette (Messenger: Health System Administrator)
Intervention Description
Visual campaign emphasizing the effectiveness and value of medications to treat opioid use disorder in saving lives combined with a narrative vignette told from the perspective of a health system administrator/leader
Primary Outcome Measure Information:
Title
Rating of willingness to have person with opioid use disorder marry into their family
Description
Item from the Social Distance Scale that measures one element of stigma (desire for social distance). Measured on 5-point Likert scale with 5 indicating greater unwillingness and 1 indicating greater willingness to have a person with opioid use disorder marry into the family. Measured via survey questionnaire.
Time Frame
Measured immediately post-exposure to message frame intervention
Title
Rating of willingness to have person with opioid use disorder as a neighbor
Description
Item from the Social Distance Scale that measures one element of stigma (desire for social distance). Measured on 5-point Likert scale with 5 indicating greater unwillingness and 1 indicating greater willingness to have a person with opioid use disorder as a neighbor. Measured via survey questionnaire.
Time Frame
Measured immediately post-exposure to message frame intervention
Title
Rating of agreement that opioid use disorder is a medical condition
Description
Rating of agreement with statement "Opioid use disorder is a chronic medical condition like diabetes mellitus" on 5-point Likert scale with 5 indicating strong disagreement and 1 indicating strong agreement. Measured via survey questionnaire.
Time Frame
Measured immediately post-exposure to message frame intervention
Title
Rating of agreement that individuals with opioid use disorder are to blame
Description
Rating of agreement with statement "Individuals with opioid use disorder only have themselves to blame for their problem" on 5-point Likert scale with 5 indicating strong disagreement and 1 indicating strong agreement. Measured via survey questionnaire.
Time Frame
Measured immediately post-exposure to message frame intervention
Title
Rating of support for increasing government spending on opioid use disorder treatment
Description
Rating of support for increasing government spending on treatment of opioid use disorder with 5 indicating strongly favoring and 1 indicating strongly opposing. Measured via survey questionnaire.
Time Frame
Measured immediately post-exposure to message frame intervention
Title
Feeling thermometer measure of warmth toward people with opioid use disorder
Description
Rating of warmth felt toward people with opioid use disorder with 0 indicating extremely cold and 100 indicating extremely warm. Measured via survey questionnaire.
Time Frame
Measured immediately post-exposure to message frame intervention
Secondary Outcome Measure Information:
Title
Stigmatizing Language - Addict
Description
Rating of agreement that term "addict" appropriate in a clinical care setting with 1 indicating strongly agree (that term is appropriate) and 5 indicating strongly disagree (that term is appropriate). Measured via survey questionnaire.
Time Frame
Measured immediately post-exposure to message frame intervention
Title
Stigmatizing Language - Substance abuse
Description
Rating of agreement that term "substance abuse" appropriate in a clinical care setting with 1 indicating strongly agree (that term is appropriate) and 5 indicating strongly disagree (that term is appropriate). Measured via survey questionnaire.
Time Frame
Measured immediately post-exposure to message frame intervention
Title
Stigmatizing Language - dirty
Description
Rating of agreement that term "'dirty' in reference to the result from a drug test" appropriate in a clinical care setting with 1 indicating strongly agree (that term is appropriate) and 5 indicating strongly disagree (that term is appropriate). Measured via survey questionnaire.
Time Frame
Measured immediately post-exposure to message frame intervention
Title
Stigmatizing Language - clean
Description
Rating of agreement that term "'clean' in reference to the result from a drug test" appropriate in a clinical care setting with 1 indicating strongly agree (that term is appropriate) and 5 indicating strongly disagree (that term is appropriate). Measured via survey questionnaire.
Time Frame
Measured immediately post-exposure to message frame intervention
Title
Stigmatizing Language - addicted baby
Description
Rating of agreement that term "addicted baby" appropriate in a clinical care setting with 1 indicating strongly agree (that term is appropriate) and 5 indicating strongly disagree (that term is appropriate). Measured via survey questionnaire.
Time Frame
Measured immediately post-exposure to message frame intervention
Title
Stigmatizing Language - person with substance use disorder
Description
Rating of agreement that term "person with substance use disorder" appropriate in a clinical care setting with 1 indicating strongly agree (that term is appropriate) and 5 indicating strongly disagree (that term is appropriate). Measured via survey questionnaire.
Time Frame
Measured immediately post-exposure to message frame intervention
Title
Stigmatizing Language - substance use
Description
Rating of agreement that term "substance use" appropriate in a clinical care setting with 1 indicating strongly agree (that term is appropriate) and 5 indicating strongly disagree (that term is appropriate). Measured via survey questionnaire.
Time Frame
Measured immediately post-exposure to message frame intervention
Title
Stigmatizing Language - negative test result
Description
Rating of agreement that term "negative test result" appropriate in a clinical care setting with 1 indicating strongly agree (that term is appropriate) and 5 indicating strongly disagree (that term is appropriate). Measured via survey questionnaire.
Time Frame
Measured immediately post-exposure to message frame intervention
Title
Stigmatizing Language - positive test result
Description
Rating of agreement that term "positive test result" appropriate in a clinical care setting with 1 indicating strongly agree (that term is appropriate) and 5 indicating strongly disagree (that term is appropriate). Measured via survey questionnaire.
Time Frame
Measured immediately post-exposure to message frame intervention
Title
Stigmatizing Language - baby born with neonatal opioid withdrawal syndrome
Description
Rating of agreement that term "baby born with neonatal opioid withdrawal syndrome" appropriate in a clinical care setting with 1 indicating strongly agree (that term is appropriate) and 5 indicating strongly disagree (that term is appropriate). Measured via survey questionnaire.
Time Frame
Measured immediately post-exposure to message frame intervention
Title
Willingness to sign pledge committing to using non-stigmatizing language
Description
Binary (yes/no) measure of whether participant is willing to sign a pledge committing to using non-stigmatizing language related to substance use disorder in clinical settings. Measured via survey questionnaire.
Time Frame
Measured immediately post-exposure to message frame intervention
Title
Perception of opioid use disorder treatment effectiveness
Description
Participant perception of whether there is a treatment for opioid use disorder that is effective for a long period of time (three close-ended response options: yes, there is a treatment; no, there isn't such a treatment; don't know). Measured via survey questionnaire.
Time Frame
Measured immediately post-exposure to message frame intervention
Title
Rating of willingness to have person taking medication marry into their family
Description
Rating of willingness to have person taking medication to treat opioid use disorder marry into family. Item from the Social Distance Scale that measures one element of stigma (desire for social distance). Measured on 5-point Likert scale with 5 indicating greater unwillingness and 1 indicating greater willingness to have a person taking medication to treat opioid use disorder marry into the family. Measured via survey questionnaire.
Time Frame
Measured immediately post-exposure to message frame intervention
Title
Rating of willingness to have person taking medication marry as a neighbor
Description
Rating of willingness to have person taking medication to treat opioid use disorder as a neighbor. Item from the Social Distance Scale that measures one element of stigma (desire for social distance). Measured on 5-point Likert scale with 5 indicating greater unwillingness and 1 indicating greater willingness to have a person taking medication to treat opioid use disorder as a neighbor. Measured via survey questionnaire.
Time Frame
Measured immediately post-exposure to message frame intervention
Title
Rating of strength/weakness of person taking medication
Description
Rating of strength/weakness of person taking medication to treat opioid use disorder on 5-point Likert scale with 5 indicating strong and 1 indicating weak. This is a semantic differential measure. Measured via survey questionnaire.
Time Frame
Measured immediately post-exposure to message frame intervention
Title
Rating of agreement that recovery is possible
Description
Rating of agreement with statement "Most people with opioid use disorder will, with medication treatment, get well and return to productive lives" on a 5-point Likert scale with 5 indicating strongly disagree and 1 indicating strongly agree. Measured via survey questionnaire.
Time Frame
Measured immediately post-exposure to message frame intervention
Title
Feeling thermometer measure of warmth toward people taking medication
Description
Rating of warmth felt toward people taking medication to treat opioid use disorder with 0 indicating extremely cold and 100 indicating extremely warm. Measured via survey questionnaire.
Time Frame
Measured immediately post-exposure to message frame intervention
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
employed as health professional in the United States, including clinicians (e.g., physicians, nurses, physician assistants, pharmacists, and optometrists), technicians and technologists (e.g., laboratory technologist or technician, emergency medical technician, paramedic, licensed practical or licensed vocational nurse, medical records or health information technician, etc.), health aids and assistants (e.g., nursing aide, home health aide, medical assistant, pharmacy aide, phlebotomist, etc.)
participant in existing web-based survey panel (IPSOS's KnowledgeNetworks panel and partner opt-in panel)
Exclusion Criteria:
not employed in health profession
not able to complete experiment and survey in English
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Alene Kennedy-Hendricks, PhD
Organizational Affiliation
Johns Hopkins Bloomberg School of Public Health
Official's Role
Principal Investigator
Facility Information:
Facility Name
Johns Hopkins Bloomberg School of Public Health
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21205
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
35119460
Citation
Kennedy-Hendricks A, McGinty EE, Summers A, Krenn S, Fingerhood MI, Barry CL. Effect of Exposure to Visual Campaigns and Narrative Vignettes on Addiction Stigma Among Health Care Professionals: A Randomized Clinical Trial. JAMA Netw Open. 2022 Feb 1;5(2):e2146971. doi: 10.1001/jamanetworkopen.2021.46971.
Results Reference
derived
Learn more about this trial
Strategies to Reduce Addiction Stigma Among Health Professionals
We'll reach out to this number within 24 hrs